{"count": 5, "results": [{"_id": "34421611", "pmid": 34421611, "pmcid": "PMC8371459", "title": "Metformin Attenuates Bone Cancer Pain by Reducing TRPV1 and ASIC3 Expression", "journal": "Front Pharmacol", "authors": ["Qian HY", "Zhou F", "Wu R", "Cao XJ", "Zhu T", "Yuan HD", "Chen YN", "Zhang PA"], "date": "2021-08-04T00:00:00Z", "doi": "10.3389/fphar.2021.713944", "meta_date_publication": "2021", "meta_volume": "12", "meta_issue": "", "meta_pages": "713944", "score": 50293.312, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Attenuates @<m>DISEASE_Bone_Neoplasms</m> @DISEASE_MESH:D001859 @@@Bone Cancer Pain@@@ by Reducing @GENE_TRPV1 @GENE_83810 @@@TRPV1@@@ and @GENE_ASIC3 @GENE_286920 @@@ASIC3@@@ Expression", "citations": {"NLM": "Qian HY, Zhou F, Wu R, Cao XJ, Zhu T, Yuan HD, Chen YN, Zhang PA. Metformin Attenuates Bone Cancer Pain by Reducing TRPV1 and ASIC3 Expression Front Pharmacol. 2021;12():713944. PMID: 34421611", "BibTeX": "@article{34421611, title={Metformin Attenuates Bone Cancer Pain by Reducing TRPV1 and ASIC3 Expression}, author={Qian HY and Zhou F and Wu R and Cao XJ and Zhu T and Yuan HD and Chen YN and Zhang PA}, journal={Front Pharmacol}, volume={12}, pages={713944}}"}}, {"_id": "34116220", "pmid": 34116220, "title": "Metformin and primary bone cancer risk in Taiwanese patients with type 2 diabetes mellitus.", "journal": "Bone", "authors": ["Tseng CH"], "date": "2021-10-01T00:00:00Z", "doi": "10.1016/j.bone.2021.116037", "meta_date_publication": "2021 Oct", "meta_volume": "151", "meta_issue": "", "meta_pages": "116037", "score": 50263.723, "text_hl": "BACKGROUND: The effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on primary @<m>DISEASE_Bone_Neoplasms</m> @DISEASE_MESH:D001859 @@@bone cancer@@@ risk has not been researched. ", "citations": {"NLM": "Tseng CH. Metformin and primary bone cancer risk in Taiwanese patients with type 2 diabetes mellitus. Bone. 2021 Oct;151():116037. PMID: 34116220", "BibTeX": "@article{34116220, title={Metformin and primary bone cancer risk in Taiwanese patients with type 2 diabetes mellitus.}, author={Tseng CH}, journal={Bone}, volume={151}, pages={116037}}"}}, {"_id": "33545810", "pmid": 33545810, "title": "Dual-functional scaffolds of poly(L-lactic acid)/nanohydroxyapatite encapsulated with metformin: Simultaneous enhancement of bone repair and bone tumor inhibition.", "journal": "Mater Sci Eng C Mater Biol Appl", "authors": ["Tan W", "Gao C", "Feng P", "Liu Q", "Liu C", "Wang Z", "Deng Y", "Shuai C"], "date": "2021-01-01T00:00:00Z", "doi": "10.1016/j.msec.2020.111592", "meta_date_publication": "2021 Jan", "meta_volume": "120", "meta_issue": "", "meta_pages": "111592", "score": 50258.215, "text_hl": "Dual-functional scaffolds of @CHEMICAL_poly(lactide) @CHEMICAL_MESH:C033616 @@@poly(L-lactic acid)@@@/nanohydroxyapatite encapsulated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@: Simultaneous enhancement of bone repair and @<m>DISEASE_Bone_Neoplasms</m> @DISEASE_MESH:D001859 @@@bone tumor@@@ inhibition.", "citations": {"NLM": "Tan W, Gao C, Feng P, Liu Q, Liu C, Wang Z, Deng Y, Shuai C. Dual-functional scaffolds of poly(L-lactic acid)/nanohydroxyapatite encapsulated with metformin: Simultaneous enhancement of bone repair and bone tumor inhibition. Mater Sci Eng C Mater Biol Appl. 2021 Jan;120():111592. PMID: 33545810", "BibTeX": "@article{33545810, title={Dual-functional scaffolds of poly(L-lactic acid)/nanohydroxyapatite encapsulated with metformin: Simultaneous enhancement of bone repair and bone tumor inhibition.}, author={Tan W and Gao C and Feng P and Liu Q and Liu C and Wang Z and Deng Y and Shuai C}, journal={Mater Sci Eng C Mater Biol Appl}, volume={120}, pages={111592}}"}}, {"_id": "36474458", "pmid": 36474458, "title": "Metformin: new applications for an old drug.", "journal": "J Basic Clin Physiol Pharmacol", "authors": ["Naseri A", "Sanaie S", "Hamzehzadeh S", "Seyedi-Sahebari S", "Hosseini MS", "Gholipour-Khalili E", "Rezazadeh-Gavgani E", "Majidazar R", "Seraji P", "Daneshvar S", "Rezazadeh-Gavgani E"], "date": "2022-12-07T00:00:00Z", "doi": "10.1515/jbcpp-2022-0252", "meta_date_publication": "2022 Dec 7", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50256.816, "text_hl": "There is evidence of the beneficial effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @DISEASE_Colorectal_Neoplasms @DISEASE_MESH:D015179 @@@colorectal cancer@@@, early-stage @DISEASE_Prostatic_Neoplasms @DISEASE_MESH:D011471 @@@prostate cancer@@@, @DISEASE_Breast_Neoplasms @DISEASE_MESH:D001943 @@@breast cancer@@@, @DISEASE_Urethral_Neoplasms @DISEASE_MESH:D014523 @@@urothelial cancer@@@, @DISEASE_Hematologic_Neoplasms @DISEASE_MESH:D019337 @@@blood cancer@@@, @DISEASE_Melanoma @DISEASE_MESH:D008545 @@@melanoma@@@, and @<m>DISEASE_Bone_Neoplasms</m> @DISEASE_MESH:D001859 @@@bone cancer@@@, suggesting @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ as a potent anti-@DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumor@@@ agent. ", "citations": {"NLM": "Naseri A, Sanaie S, Hamzehzadeh S, Seyedi-Sahebari S, Hosseini MS, Gholipour-Khalili E, Rezazadeh-Gavgani E, Majidazar R, Seraji P, Daneshvar S, Rezazadeh-Gavgani E. Metformin: new applications for an old drug. J Basic Clin Physiol Pharmacol. 2022 Dec 7;():. PMID: 36474458", "BibTeX": "@article{36474458, title={Metformin: new applications for an old drug.}, author={Naseri A and Sanaie S and Hamzehzadeh S and Seyedi-Sahebari S and Hosseini MS and Gholipour-Khalili E and Rezazadeh-Gavgani E and Majidazar R and Seraji P and Daneshvar S and Rezazadeh-Gavgani E}, journal={J Basic Clin Physiol Pharmacol}}"}}, {"_id": "24074896", "pmid": 24074896, "title": "Inhibitory effect of metformin on bone metastasis of cancer via OPG/RANKL/RANK system.", "journal": "Med Hypotheses", "authors": ["Wang J", "Chen TY", "Qin S", "Duan Y", "Wang G"], "date": "2013-11-01T00:00:00Z", "doi": "10.1016/j.mehy.2013.08.032", "meta_date_publication": "2013 Nov", "meta_volume": "81", "meta_issue": "5", "meta_pages": "805-6", "score": 50063.96, "text_hl": "Inhibitory effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @<m>DISEASE_Bone_Neoplasms</m> @DISEASE_MESH:D001859 @@@bone metastasis of cancer@@@ via @GENE_BTF3P11 @GENE_690 @@@OPG@@@/@GENE_TNFSF11 @GENE_8600 @@@RANKL@@@/RANK system.", "citations": {"NLM": "Wang J, Chen TY, Qin S, Duan Y, Wang G. Inhibitory effect of metformin on bone metastasis of cancer via OPG/RANKL/RANK system. Med Hypotheses. 2013 Nov;81(5):805-6. PMID: 24074896", "BibTeX": "@article{24074896, title={Inhibitory effect of metformin on bone metastasis of cancer via OPG/RANKL/RANK system.}, author={Wang J and Chen TY and Qin S and Duan Y and Wang G}, journal={Med Hypotheses}, volume={81}, number={5}, pages={805-6}}"}}]}